CDX-011 (Glembatumumab vedotin, CR011-vcMMAE)

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Citation (Scopus)

Original language	English (US)
Title of host publication	Antibody-Drug Conjugates and Immunotoxins
Subtitle of host publication	From Pre-Clinical Development to Therapeutic Applications
Publisher	Springer New York
Pages	211-220
Number of pages	10
ISBN (Electronic)	9781461454564
ISBN (Print)	9781461454557
DOIs	https://doi.org/10.1007/978-1-4614-5456-4_12
Publication status	Published - 1 Jan 2013
Externally published	Yes

Access to Document

@inbook{ddfd3eb0e9b844aaa45cc383f2fa9b0a,

title = "CDX-011 (Glembatumumab vedotin, CR011-vcMMAE)",

author = "Christos Vaklavas and LoBuglio, \{Albert F.\} and Mansoor Saleh and Michael Yelin and Andres Forero",

year = "2013",

month = jan,

day = "1",

doi = "10.1007/978-1-4614-5456-4\_12",

language = "English (US)",

isbn = "9781461454557",

pages = "211--220",

booktitle = "Antibody-Drug Conjugates and Immunotoxins",

publisher = "Springer New York",

address = "United States",

}

TY - CHAP

T1 - CDX-011 (Glembatumumab vedotin, CR011-vcMMAE)

AU - Vaklavas, Christos

AU - LoBuglio, Albert F.

AU - Saleh, Mansoor

AU - Yelin, Michael

AU - Forero, Andres

PY - 2013/1/1

Y1 - 2013/1/1

UR - https://www.scopus.com/pages/publications/84971629368

U2 - 10.1007/978-1-4614-5456-4_12

DO - 10.1007/978-1-4614-5456-4_12

M3 - Chapter

AN - SCOPUS:84971629368

SN - 9781461454557

SP - 211

EP - 220

BT - Antibody-Drug Conjugates and Immunotoxins

PB - Springer New York

ER -